Dulaglutide is cardioprotective with or without background metformin in patients with diabetes and established or high risk for coronary vascular disease. A subgroup analysis of the REWIND Trial.

Back

ESC Premium Access

Dulaglutide is cardioprotective with or without background metformin in patients with diabetes and established or high risk for coronary vascular disease. A subgroup analysis of the REWIND Trial.

Session: Improving Cardiovascular Function and Clinical Outcome in Diabetes Using New Guideline-Based Pharmacotherapy

Topic: Antidiabetic Pharmacotherapy

Speaker: Doctor G. Ferrannini (Stockholm, SE)

Event: ESC Congress 2020

Congress Presentation

Add to my library

About the speaker

Doctor Giulia Ferrannini

Karolinska Institute, Stockholm (Sweden)

2 presentations

0 follower

7 more presentations in this session

Cardiovascular outcomes in patients with type 2 diabetes and reduced eGFR and albuminuria: a REWIND post hoc subgroup analysis

Speaker: Professor H. Colhoun (Edinburgh, GB)

Direct effects of canagliflozin on human myocardial redox signalling: a novel role for SGLT1 inhibition

Speaker: Doctor H. Kondo (Yufu City, JP)

Impact of polyvascular disease and renal dysfunction on cardiovascular outcomes in diabetes: post hoc analyses from EMPA-REG OUTCOME

Speaker: Professor S. Verma (Toronto, CA)

Natriuretic effect of 2 weeks of dapagliflozin treatment in patients with type 2 diabetes and preserved kidney function: results of the DAPASALT trial

Speaker: Professor H. Heerspink (Groningen, NL)

The effects of empagliflozin on arterial stiffness, endothelial function and ventriculoarterial coupling in type 2 diabetes mellitus: 1 year follow up

Speaker: Doctor I. Ikonomidis (Athens, GR)

Access the full session

Improving Cardiovascular Function and Clinical Outcome in Diabetes Using New Guideline-Based Pharmacotherapy

Speakers: Doctor G. Ferrannini, Professor H. Colhoun, Doctor H. Kondo, Professor S. Verma, Professor H. Heerspink...

Access

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources